Market Overview

It's Time To Kick The Habit Restaurants, Baird Analyst Says

Share:
It's Time To Kick The Habit Restaurants, Baird Analyst Says
Related HABT
A Few Takeaways From Guggenheim's Restaurant Summit: Darden, Habit, El Pollo And Wingstop
Podcast: Burger Stocks, Tasty Or Not?

Habit Restaurants Inc (NASDAQ: HABT) was downgraded by Baird after it reported third-quarter results after the close Wednesday that analyst David Tarantino termed "disappointing." 

The results indicated weaker-than-expected comps and continued cost headwinds, Tarantino said. Despite the top-line holding up amid a challenging industrial backdrop, the third quarter results showed that the company's earnings model has little margin for error in the current competitive backdrop, the analyst said. 

Baird downgraded Habit Restaurants from Outperform to Neutral and lowered its price target from $20 to $12. 

At the time of writing, shares of Habit Restaurants were slumping 22.67 percent to $9.55.

The Irvine, California-based company reported a Q3 adjusted EPS of $0.01 against a $0.03 estimate and sales of $84.6 million, falling short of a $85.8 million estimate. 

A Better Habit In The Long Term

The two main issues weighing on Habit Restaurant's fundamentals, namely competitive discounting and hefty cost inflation, are unlikely to abate in the coming quarters, Tarantino said. Notwithstanding management's efforts to tackle these issues, the analyst said visibility on better comps and profit momentum is lower.

Baird remains bullish on the longer-term growth potential of the business, with the firm seeing scope for a more positive rating if it gains confidence in near-term fundamentals, Tarantino said. Habit's prospective valuation metrics are reasonable for patient investors who are able to look past today's headwinds, the analyst said. 

Delving into the key third quarter numbers, Tarantino said the company's pro forma EBITDA was down 16 percent, well below the 2-percent drop estimated by the Street, primarily due to weaker-than-expected comps and EBITDA margins. 

Habit lowered its full year guidance for revenue, comps and restaurant margin, according to Baird. 

While remaining cautiously optimistic concerning the near-term, Taranto said there's risk that newer sales drivers such as increased advertising and innovating on value-oriented price points could take time to gain traction amid an intensifying promotional environment.

McDonald's Corporation (NYSE: MCD) is set to launch its national value platform in 2018, Tarantino said. 

Baird lowered its EBITDA estimates by 13 percent for 2017 by 20 percent for 2018. 

Related Links: 

Whet Your Restaurant Sector Appetite: A 2017 Outlook

3 Restaurants These Analysts No Longer Have An Appetite For 

Photo courtesy of Habit Burger. 

Latest Ratings for HABT

DateFirmActionFromTo
Oct 2018GuggenheimMaintainsBuyBuy
Aug 2018Maxim GroupDowngradesBuyHold
Aug 2018Maxim GroupMaintainsBuyBuy

View More Analyst Ratings for HABT
View the Latest Analyst Ratings

Posted-In: Baird David TarantinoAnalyst Color Downgrades Price Target Restaurants Analyst Ratings General Best of Benzinga

 

Related Articles (MCD + HABT)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
MOSJP MorganDowngrades33.0
BACKeefe Bruyette & WoodsDowngrades29.0
AMTMorgan StanleyDowngrades170.0
EBAYMorgan StanleyDowngrades33.0
UNITMorgan StanleyDowngrades16.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Mallinkcrodt Is Betting On Ocera Despite Doubts Around Its Liver Disease Drug

Mid-Afternoon Market Update: Ocera Therapeutics Surges Following Acquisition News; IMPINJ Shares Plunge